PLAUR and pulmonary fibrosis: Finally, we found that mouse plasminogen intravenous administration (1 mg) could reverse lung fibrosis by reducing more than two-fold the fibrotic lung area in mice lacking uPAR expression (Plaur-/-) at day 42 after fibrosis induction.